Strive Reports Massive Annual Loss Driven by Bitcoin Volatility and Impairments; Details Ongoing Capital Raises

summarizeSummary

Strive, Inc. filed its 2025 annual report, revealing a substantial net loss of $393.6 million, primarily due to unrealized losses on digital assets and goodwill impairment, alongside details of its bitcoin treasury strategy and ongoing capital market activities.

check_boxKey Events

• Significant Financial Losses

  Reported a net loss of $393.6 million for the period from September 12 to December 31, 2025, primarily driven by a $194.5 million net unrealized loss on digital assets and a $140.8 million goodwill and intangible asset impairment.

• Bitcoin Treasury Strategy Update

  Acquired 7,627 bitcoin in 2025 for an aggregate cost of $863.0 million, with a fair value of $668.5 million as of December 31, 2025. Subsequent to year-end (January 1, 2026 to March 17, 2026), acquired an additional 5,048 bitcoin through the Semler Scientific merger and purchased 953 more, bringing total holdings to 13,628 bitcoin.

• Legal Settlement for Subsidiary

  Semler Scientific, a wholly-owned subsidiary acquired in January 2026, agreed to a $29.8 million settlement with the U.S. Department of Justice for alleged False Claims Act violations pertaining to its medical devices, effective September 10, 2025.

• Ongoing Capital Raising Activities

  Detailed existing at-the-market (ATM) offering programs for Class A Common Stock (up to $450.0 million, with $78.7 million sold in 2025 and $95.0 million sold from January 1 to March 17, 2026) and Variable Rate Series A Perpetual Preferred Stock (up to $500.0 million, with $1.2 million sold in 2025 and $1.2 million sold from January 1 to March 17, 2026).

auto_awesomeAnalysis

Strive's 2025 annual report highlights the significant financial risks associated with its bitcoin treasury strategy, with substantial losses from digital asset revaluation and impairment charges overshadowing its operational revenues. The company's aggressive bitcoin acquisition strategy, while expanding its holdings, exposes it to extreme market volatility. The legal settlement inherited from the Semler Scientific acquisition adds another layer of financial burden. While ongoing capital raises provide necessary liquidity, they also signal continued reliance on external funding and potential dilution for shareholders. Investors should closely monitor bitcoin price movements, the company's ability to generate sustainable operating profits from its asset management and healthcare segments, and the execution of its capital allocation strategy amidst these considerable financial headwinds.